Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from A chemoresistance-associated proliferation gene signature identified by single-cell and machine learning analysis predicts prognosis in high-grade serous ovarian carcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017
10.1016/j.eclinm.2024.102983 · 2025 · External reference
Global burden and projected trends of ovarian cancer in older women: a GBD 2021 analysis
2026 · External reference
On behalf of Ncd Global Health Research Group of Association of Pacific Rim Universities, worldwide burden, risk factors, and temporal trends of ovarian cancer: a Global study
10.3390/cancers14092230 · 2022 · External reference
Deciphering ovarian cancer heterogeneity through spatial transcriptomics, single-cell profiling, and copy number variations
2025 · External reference
Multiomic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma
10.1158/0008-5472.can-20-0521 · 2020 · External reference
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
10.1002/path.2696 · 2010 · External reference
Genomic characterization of high-grade serous ovarian cancer: dissecting its molecular heterogeneity as a road towards effective therapeutic strategies
10.1007/s11912-016-0526-9 · 2016 · External reference
Identification of tumor doubling time-related subtypes and construction of risk models to predict prognosis and immunological features in breast cancer
10.4143/crt.2025.948 · 2025 · External reference
Growth kinetics of high-grade serous ovarian cancer: implications for early detection
10.1038/s41416-025-03082-6 · 2025 · External reference
Transcriptomic subtypes in high-grade serous ovarian cancer are driven by tumor cellular composition
2026 · External reference
Integrated genomic analyses of ovarian carcinoma
2011 · External reference
Integrative single-cell and machine learning analysis identifies a tumor doubling time-related prognostic signature and therapeutic targets in head and neck squamous cell carcinoma
10.1016/j.tranon.2026.102927 · 2026 · External reference
Single-cell and machine learning approaches uncover intrinsic immune-evasion genes in the prognosis of hepatocellular carcinoma
10.1016/j.livres.2024.11.001 · 2024 · External reference
Mechanosensitive ion channel-related genes in hepatocellular carcinoma: unraveling prognostic genes and their roles in drug resistance and immune modulation
10.1016/j.livres.2025.01.002 · 2025 · External reference
Key genes associated with non-alcoholic fatty liver disease and hepatocellular carcinoma with metabolic risk factors
2023 · External reference
Integrative single-cell and spatial transcriptomics analysis reveals a baicalein-responsive 10-gene signature for non-small cell lung cancer
10.1016/j.tranon.2026.102853 · 2026 · External reference
scTenifoldKnk: an efficient virtual knockout tool for gene function predictions via single-cell gene regulatory network perturbation
10.1016/j.patter.2022.100434 · 2022 · External reference
Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer
2015 · External reference
Nucleolar NOL9 regulated by DNA methylation promotes hepatocellular carcinoma growth through activation of wnt/β-catenin signaling pathway
10.1038/s41419-025-07393-7 · 2025 · External reference
Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
10.1186/s13046-019-1362-1 · 2019 · External reference
10.1186/1757-2215-4-20 · 2011 · Admitted local publication
CENPH overexpression promotes the progression, cisplatin resistance, and poor prognosis of lung adenocarcinoma via the AKT and ERK/P38 pathways
2023 · External reference
PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma
10.1038/s41419-019-1415-6 · 2019 · External reference
10.21203/rs.3.rs-961590/v1
10.21203/rs.3.rs-961590/v1 · External reference
Identification of lactylation-related subtypes, construction of prognostic scoring model and immunotherapy prediction in ovarian cancer
2025 · External reference
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer
10.1002/ijc.32935 · 2020 · External reference
SDF2L1 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma
10.1155/2020/7020924 · 2020 · External reference
TEAD4 predicts poor prognosis and transcriptionally targets PLAGL2 in serous ovarian cancer
10.1007/s13577-023-00908-4 · 2023 · External reference
Tropomyosin3 overexpression and a potential link to epithelial-mesenchymal transition in human hepatocellular carcinoma
10.1186/1471-2407-10-122 · 2010 · External reference
PUF60 Promotes chemoresistance through drug efflux and reducing apoptosis in gastric cancer
10.7150/ijms.102976 · 2025 · External reference
Cancer-associated stroma significantly contributes to the mesenchymal subtype signature of serous ovarian cancer
10.1016/j.ygyno.2018.11.014 · 2019 · External reference
Combined CCNE1 high-level amplification and overexpression is associated with unfavourable outcome in tubo-ovarian high-grade serous carcinoma
10.1002/cjp2.168 · 2020 · External reference
Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer
10.3389/fonc.2025.1633410 · 2025 · External reference
